Eli Lilly to present 16 AAIC 2026 abstracts on Kisunla and diagnostics
The company said three oral sessions and 13 posters will cover long-term donanemab data, P-tau217 blood testing and Alzheimer's trial methodology at the July 12-15 London meeting.